BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 30989488)

  • 1. Comparison of CDH1 Gene Hypermethylation Status in Blood and Serum among Gastric Cancer Patients.
    Li Z; Guo Z
    Pathol Oncol Res; 2020 Apr; 26(2):1057-1062. PubMed ID: 30989488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypermethylation Status of E-Cadherin Gene in Gastric Cancer Patients in a High Incidence Area.
    Rashid H; Alam K; Afroze D; Yousuf A; Banday M; Kawoosa F
    Asian Pac J Cancer Prev; 2016; 17(6):2757-60. PubMed ID: 27356686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined analysis of E-cadherin gene (CDH1) promoter hypermethylation and E-cadherin protein expression in patients with gastric cancer: implications for treatment with demethylating drugs.
    Graziano F; Arduini F; Ruzzo A; Mandolesi A; Bearzi I; Silva R; Muretto P; Testa E; Mari D; Magnani M; Scartozzi M; Cascinu S
    Ann Oncol; 2004 Mar; 15(3):489-92. PubMed ID: 14998854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CDH1 gene promoter hypermethylation in gastric cancer: relationship to Goseki grading, microsatellite instability status, and EBV invasion.
    Zazula M; Ferreira AM; Czopek JP; Kolodziejczyk P; Sinczak-Kuta A; Klimkowska A; Wojcik P; Okon K; Bialas M; Kulig J; Stachura J
    Diagn Mol Pathol; 2006 Mar; 15(1):24-9. PubMed ID: 16531765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic analysis of E-cadherin gene promoter hypermethylation in patients with surgically resected, node-positive, diffuse gastric cancer.
    Graziano F; Arduini F; Ruzzo A; Bearzi I; Humar B; More H; Silva R; Muretto P; Guilford P; Testa E; Mari D; Magnani M; Cascinu S
    Clin Cancer Res; 2004 Apr; 10(8):2784-9. PubMed ID: 15102685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of germline mono-allelic promoter hypermethylation of the CDH1 gene in gastric cancer patients.
    Yamada H; Shinmura K; Goto M; Iwaizumi M; Konno H; Kataoka H; Yamada M; Ozawa T; Tsuneyoshi T; Tanioka F; Sugimura H
    Mol Cancer; 2009 Aug; 8():63. PubMed ID: 19671196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Methylation status of CDH1 gene in preoperative abdominal lavage of patients with gastric cancer and its clinical significance].
    Luo J; Wang XB; Yu QM; Zhao T; Fang RG; Wang JJ; Zheng ZG; Yu JL; Fang XH; Wang S; Ling ZQ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Jul; 15(7):710-4. PubMed ID: 22851076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promoter hypermethylation of CDH1, FHIT, MTAP and PLAGL1 in gastric adenocarcinoma in individuals from Northern Brazil.
    Leal M; Lima E; Silva P; Assumpção P; Calcagno D; Payão S; Burbano RR; Smith M
    World J Gastroenterol; 2007 May; 13(18):2568-74. PubMed ID: 17552003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct promoter hypermethylation of p16INK4a, CDH1, and RAR-beta in intestinal, diffuse-adherent, and diffuse-scattered type gastric carcinomas.
    Oue N; Motoshita J; Yokozaki H; Hayashi K; Tahara E; Taniyama K; Matsusaki K; Yasui W
    J Pathol; 2002 Sep; 198(1):55-9. PubMed ID: 12210063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of expression and aberrant methylation of the CDH1 (E-cadherin) gene in breast cancer patients from Kashmir.
    Asiaf A; Ahmad ST; Aziz SA; Malik AA; Rasool Z; Masood A; Zargar MA
    Asian Pac J Cancer Prev; 2014; 15(15):6397-403. PubMed ID: 25124632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CDH1 methylation in preoperative peritoneal washes is an independent prognostic factor for gastric cancer.
    Yu QM; Wang XB; Luo J; Wang S; Fang XH; Yu JL; Ling ZQ
    J Surg Oncol; 2012 Nov; 106(6):765-71. PubMed ID: 22514028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promoter hypermethylation may contribute to E‑cadherin repression in the human salivary carcinoma ex pleomorphic adenoma.
    Xia L; Hu Y; Gu T; Wang L; Tian Z
    Int J Oncol; 2018 Feb; 52(2):496-504. PubMed ID: 29207084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of genetic variants in and promoter hypermethylation of CDH1 with gastric cancer: a meta-analysis.
    Jing H; Dai F; Zhao C; Yang J; Li L; Kota P; Mao L; Xiang K; Zheng C; Yang J
    Medicine (Baltimore); 2014 Oct; 93(19):e107. PubMed ID: 25340495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CpG island promoter methylation (CIHM) status of tumor suppressor genes correlates with morphological appearances of gastric cancer.
    Tahara T; Shibata T; Arisawa T; Nakamura M; Yamashita H; Yoshioka D; Okubo M; Yonemura J; Maeda Y; Maruyama N; Kamano T; Kamiya Y; Fujita H; Nakagawa Y; Nagasaka M; Iwata M; Hirata I
    Anticancer Res; 2010 Jan; 30(1):239-44. PubMed ID: 20150642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promoter hypermethylation of the tumor-suppressor genes RASSF1A, GSTP1 and CDH1 in endometrial cancer.
    Fiolka R; Zubor P; Janusicova V; Visnovsky J; Mendelova A; Kajo K; Lasabova Z; Plank L; Danko J
    Oncol Rep; 2013 Dec; 30(6):2878-86. PubMed ID: 24068440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypermethylation-modulated down-regulation of CDH1 expression contributes to the progression of esophageal cancer.
    Ling ZQ; Li P; Ge MH; Zhao X; Hu FJ; Fang XH; Dong ZM; Mao WM
    Int J Mol Med; 2011 May; 27(5):625-35. PubMed ID: 21373750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promoter methylation of TIMP3 and CDH1 predicts better outcome in head and neck squamous cell carcinoma treated by radiotherapy only.
    De Schutter H; Geeraerts H; Verbeken E; Nuyts S
    Oncol Rep; 2009 Feb; 21(2):507-13. PubMed ID: 19148529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of expression level and methylation profile of
    Mohammadi Z; Azad M; Foroughi F; Khojastehpour S; Gheibi N; Samiee-Rad F; Maali A; Ahmadi MH
    J Cancer Res Ther; 2021; 17(6):1328-1334. PubMed ID: 34916361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinicopathological significance of CDH1 in gastric cancer: a meta-analysis and systematic review.
    Zeng W; Zhu J; Shan L; Han Z; Aerxiding P; Quhai A; Zeng F; Wang Z; Li H
    Drug Des Devel Ther; 2015; 9():2149-57. PubMed ID: 25926721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypermethylation of E-cadherin is an independent predictor of improved survival in head and neck squamous cell carcinoma.
    Marsit CJ; Posner MR; McClean MD; Kelsey KT
    Cancer; 2008 Oct; 113(7):1566-71. PubMed ID: 18711702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.